Involvement of ApoE E4 and H63D in sporadic Alzheimer's disease in a folate-supplemented Ontario population

Journal of Alzheimer's Disease

Volumn 14, Issue 1, 2008, Pages 69-84

  Percy, Maire ^a,b   Moalem, Sharon ^b,c   Garcia, Angeles ^d   Somerville, Martin J ^e   Hicks, Mark ^b   Andrews, David ^b   Azad, Azar ^f   Schwarz, Peter ^b   Zavareh, Reza Beheshti ^b   Birkan, Rivka ^b   Choo, Clara ^b   Chow, Vinca ^b   Dhaliwal, Sandeep ^b   Duda, Victoria ^b   Kupferschmidt, Anthony L ^d,g   Lam, Kyla ^b   Lightman, Deborah ^b   MacHalek, Karolina ^b   Mar, Wanna ^h   Nguyen, Frank ^b   Rytwinski, Piotr J ^b   Svara, Erin ^d   Tran, Maithy ^b   Yeung, Lisa ^b   Zanibbi, Katherine ^d   Zener, Rebecca ^b   Ziraldo, Melissa ^h   Freedman, Morris ^f   more..

^a Neurogenetics Laboratory   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d QUEEN S UNIVERSITY   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f MOUNT SINAI HOSPITAL   (Canada)

^g SIMON FRASER UNIVERSITY   (Canada)

^h ROTMAN RESEARCH INSTITUTE   (Canada)

Author keywords

APOE; Folate; HFE; Iron status; Sporadic Alzheimer's disease

Indexed keywords

APOLIPOPROTEIN E4; CYANOCOBALAMIN; FOLIC ACID; HFE PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CANADA; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; GENE FREQUENCY; GENOTYPE; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; IRON OVERLOAD; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 47849117346     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-14107     Document Type: Article

References (100)

1. R.T. Acton, J.C. Barton, B.M. Snively, C.E. McLaren, P.C. Adams, E.L. Harris, M.R. Speechley, G.D. McLaren, F.W. Dawkins, C. Leiendecker-Foster, J.L. Holup and A. Balasubramanyam, Hemochromatosis and Iron Overload Screening Study Research Investigators. Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study, Ethn Dis 16 (2006), 815-821.
2. P.N. Alexandrov, Y. Zhao, A.I. Pogue, M.A. Tarr, T.P. Kruck, M.E. Percy, J.G. Cui and W.J. Lukiw, Synergistic effects of iron and aluminum on stress-related gene expression in primary human neural cells, J Alzheimers Dis 8 (2005), 117-127.
3. B.Z. Alizadeh, O.T. Njajou, M.R. Millan, A. Hofman, M.M. Breteler and C.M. van Duijn, HFE variants, APOE and Alzheimer's disease: Findings from the population-based Rotterdam Study, Neurobiol Aging (2007), in press.
4. T. Amit, Y. Avramovich-Tirosh, M.B. Youdim and S. Mandel, Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators, FASEB J (2007), in press.
5. H.K. Anandatheerthavarada, G. Biswas, M.A. Robin and N.G. Avadhani, Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells, J Cell Biol 161 (2003), 41-54.
6. A.C. Antony, M.A. Kane, S.R. Krishnan, R.S. Kincade and R.S. Verma, Folate (pteroylglutamate) uptake in human red blood cells, erythroid precursors and KB cells at high extracellular folate concentrations, Evidence against a role for specific folate-binding and transport proteins. Biochem J 260 (1989), 401-411.
7. H. Atamna andW.H. Frey 2nd, Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease, Mitochondrion 7 (2007), 297-310.
8. N.A. Azad, M. Al Bugami and I. Loy-English, Gender differences in dementia risk factors, Gend Med 4 (2007), 120-129.
9. L.B. Bailey, G.C. Rampersaud and G.P. Kauwell, Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: Evolving science, J Nutr 133 (2003), 1961S-1968S.
10. S. Bandyopadhyay, X. Huang, H. Cho, N.H. Greig, M.B. Youdim and J.T. Rogers, Metal specificity of an ironresponsive element in Alzheimer's APP mRNA 5′untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator, J Neural Transm Suppl 71 (2006), 237-247.
11. J.C. Barton, M.A. Patton, C.Q. Edwards, L.M. Griffen, J.P. Kushner, R.G. Meeks and R.W. Leggett, Blood lead concentrations in hereditary hemochromatosis, J Lab Clin Med 124 (1994), 193-198.
12. G. Bartzokis, D. Sultzer, J. Cummings, L.E. Holt, D.B. Hance, V.W. Henderson and J. Mintz, In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging, Arch Gen Psychiatry 57 (2000), 47-53.
13. G. Bartzokis, T.A. Tishler, P.H. Lu, P. Villablanca, L.L. Altshuler, M. Carter, D. Huang, N. Edwards and J. Mintz, Brain ferritin iron may influence age- and gender-related risks of neurodegeneration, Neurobiol Aging 28 (2007), 414-423.
14. C. Behl, M. Widmann, T. Trapp and F. Holsboer, 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro, Biochem Biophys Res Commun 216 (1995), 473-482.
15. E. Beutler, Hemochromatosis, Genet Pathophysiol 57 (2006), 331-347.
16. E. Bialystok, F.I. Craik and M. Freedman M, Bilingualism as a protection against the onset of symptoms of dementia, Neuropsychologia 45 (2007), 459-464.
17. L. Blazquez, D. De Juan, J. Ruiz-Martinez, J.I. Emparanza, A. Saenz, D. Otaegui, A. Sistiaga, P. Martinez-Lage, I. Lamet, L. Samaranch, C. Buiza, I. Etxeberria I, E. Arriola, E. Cuadrado, E. Urdaneta, J. Yanguas and A. Lopez de Munain, Genes related to iron metabolism and susceptibility to Alzheimer's disease in Basque population, Neurobiol Aging 28 (2007), 1941-1943.
18. C.J. Carter, Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: Relevance to pathological-signalling cascades, Neurochem Int 52(6) (May 2008), 920-934. Epub 2007 Nov. 23. PMIDL: 18164103 [PubMed - in process].
19. R.J. Castellani, P.I. Moreira, G. Liu, J. Dobson, G. Perry, M.A. Smith and X. Zhu, Iron: The redox-active center of oxidative stress in Alzheimer disease, Neurochem Res 32 (2007), 1640-1645.
20. J. Collingwood and J. Dobson, Mapping and characterization of iron compounds in Alzheimer's tissue, J Alzheimers Dis 10 (2006), 215-222.
21. J.R. Connor and S.Y. Lee, HFE mutations and Alzheimer's disease, J Alzheimers Dis 10 (2006), 267-276.
22. K.D. Coon, A.J. Myers, D.W. Craig, J.A. Webster, J.V. Pearson, D.H. Lince, V.L. Zismann, T.G. Beach, D. Leung, L. Bryden, R.F. Halperin, L. Marlowe, M. Kaleem, D.G. Walker, R. Ravid, C.B. Heward, J. Rogers, A. Papassotiropoulos, E.M. Reiman, J. Hardy and D.A. Stephan. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease, J Clin Psychiatry 68 (2007), 613-618.
23. L. Cordain and M.S. Hickey, Ultraviolet radiation represents an evolutionary selective pressure for the south-to-north gradient of the MTHFR 677TT genotype, Am J Hum Genet 66 (2000), 1246-1258.
24. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines and M.A. Pericak-Vance, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science 261 (1993), 921-923.
25. D.R. Crapper McLachlan, A.J. Dalton, T.P. Kruck, M.Y. Bell, W.L. Smith, W. Kalow and D.F. Andrews, Intramuscular desferrioxamine in patients with Alzheimer's disease, Lancet 337 (1991), 1304-1308.
26. G. Dal Forno, K.A. Carson, R. Brookmeyer, J. Troncoso, C.H. Kawas and J. Brandt, APOE genotype and survival in men and women with Alzheimer's disease, Neurology 58 (2002), 1045-1050.
27. C. Ellervik, A. Tybjaerg-Hansen, M. Appleyard, H. Sillesen, G. Boysen and B.G. Nordestgaard, Hereditary hemochromatosis genotypes and risk of ischemic stroke, Neurology 68 (2007), 1025-1031.
28. Exact r x c Contingency Table: How many rows? columns? Retrieved August 10, 2007 from http://www.physics.csbsju.edu/stats/exact NROW NCOLUMN form.html.
29. C. Exley, A. Begum, M.P. Woolley and R.N. Bloor, Aluminum in tobacco and cannabis and smoking-related disease, Am J Med 199 (2006), 276e9-11.
30. F.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, A. Basava, F. Dormishian, R. Domingo Jr., M.C. Ellis, A. Fullan, L.M. Hinton, N.L. Jones, B.E. Kimmel, G.S. Kronmal, P. Lauer, V.K. Lee, D.B. Loeb, F.A. Mapa, E. McClelland, N.C. Meyer, G.A. Mintier, N. Moeller, T. Moore, E. Morikang, C.E. Prass, L. Quintana, S.M. Starnes, R.C. Schatzman, K.J. Brunke, D.T. Drayna, N.J. Risch, B.R. Bacon and R.K. Wolff, A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis, Nat Genet 13 (1996), 399-408.
31. C.E. Finch and T.E. Morgan, Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: A position paper, Curr Alzheimer Res 4 (2007), 185-189.
32. No authors listed, Guidelines on the investigation and diagnosis of cobalamin and folate deficiencies. A publication of the British Committee for Standards in Haematology. BCSH General Haematology Test Force, Clin Lab Haematol 16 (1994), 101-115.
33. M.R. Fokkema, M.F. Gilissen, J.J. van Doormaal, M. Volmer, I.P. Kema and F.A Muskiet, Fasting vs nonfasting plasma homocysteine concentrations for diagnosis of hyperhomocysteinemia, Clin Chem 49 (2003), 818-821.
34. G.B. Frisoni, M. Manfredi, C. Geroldi, G. Binetti, O. Zanetti, A. Bianchetti and M. Trabucchi, The prevalence of apoE-epsilon4 in Alzheimer's disease is age dependent, J Neurol Neurosurg Psychiatry 65 (1998), 103-106.
35. A. Garcia, A.G. Day, K. Zanibbi and M.V. Zunzunegui, Long-term effects of folic acid fortification and B-vitamin supplementation on total folate, homocysteine, methylmalonic acid and cobalamin in older adults, Can J Public Health (2008), in press.
36. J. Geisel, U. Hübner, M. Bodis, H. Schorr, J.P. Knapp, R. Obeid and W. Herrmann, The role of genetic factors in the development of hyperhomocysteinemia, Clin Chem Lab Med 41 (2003), 1427-1434.
37. L.U. Gerdes, The common polymorphism of apolipoprotein E: Geographical aspects and new pathophysiological relations, Clin Chem Lab Med 41 (2003), 628-631.
38. T. Goswami and N.C. Andrews, Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing, J Biol Chem 281 (2006), 28494-28498.
39. GraphPad Software (2005), Retrieved August 20, 2007, from http://www.graphpad.com/quickcalcs/contingency1.cfm.
40. W.S. Griffin, Inflammation and neurodegenerative diseases, Am J Clin Nutr 83 (2006), 470S-474S.
41. X. Han, The role of apolipoprotein E in lipid metabolism in the central nervous system, Cell Mol Life Sci 61 (2004), 1896-1906.
42. D.J.R. Hutchon, Calculator for confidence intervals of odds ratio in an unmatched case control study (2001) Retrieved July 26, 2006, http://www.hutchon.net/ConfidORnulhypo.htm
43. D. Jackson, A short review on the interpretation of iron studies. Medicine AuNews (2006), Retrieved January 26, 2008, from http://216.55.99.51/ news.html?NewsID=4485&Mode=Print.
44. Java Stat - Retrospective Power Calculation (n.d.), Retrieved July 13, 2007, from http://statpages.org/postpowr.html.
45. W.A. Jefferies, D.L. Dickstein and M. Ujiie, Assessing p97 as an Alzheimer's disease serum biomarker, J Alzheimers Dis 3 (2001), 339-344.
46. L. Jofre-Monseny, A.M. Minihane and G. Rimbach, Impact of apoE genotype on oxidative stress, inflammation and disease risk, Mol Nutr Food Res 52 (2008), 131-145.
47. R. Joshi, S. Adhikari, B.S. Patro, S. Chattopadhyay and T. Mukherjee, Free radical scavenging behavior of folic acid: Evidence for possible antioxidant activity, Free Radic Biol Med 30 (2001), 1390-1399.
48. E.M. Kawamoto, C.D. Munhoz, I. Glezer, V.S. Bahia, P. Caramelli, R. Nitrini, R. Gorjão, R. Curi, C. Scavone and T. Marcourakis, Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease, Neurobiol Aging 26 (2005), 857-864.
49. D.W. Killilea, S.L. Wong, H.S. Cahaya, H. Atamna and B.N. Ames, Iron accumulation during cellular senescence, Ann N Y Acad Sci 1019 (2004), 365-367.
50. S.Y. Lee, S.M. Patton, R.J. Henderson and J.R. Connor, Consequences of expressing mutants of the hemochromatosis gene (HFE) into a human neuronal cell line lacking endogenous HFE, FASEB J 21 (2007), 564-576.
51. D.J. Lehmann, M. Worwood, R. Ellis, V.L. Wimhurst, A.T. Merryweather-Clarke, D.R. Warden, A.D. Smith and K.J. Robson, Iron genes, iron load and risk of Alzheimer's disease, J Med Genet 43 (2006), e52.
52. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell and W.R. Markesbery, Copper, iron and zinc in Alzheimer's disease senile plaques, J Neurol Sci 158 (1998), 47-52.
53. J.A. Luchsinger, M.X. Tang, J. Miller, R. Green and R. Mayeux, Relation of higher folate intake to lower risk of Alzheimer disease in the elderly, Arch Neurol 64 (2007), 86-92.
54. G. Lucotte, F. Loirat and S. Hazout, Pattern of gradient of apolipoprotein E allele *4 frequencies in western Europe, Hum Biol 69 (1997), 253-262.
55. R.W. Mahley, Y. Huang, K.H. Weisgraber and M.P. Mattson, Putting cholesterol in its place: ApoE and reverse cholesterol transport, J Clin Invest 116 (2006), 1226-1229.
56. A.G. Mainous 3rd, S.L. Eschenbach, B.J. Wells, C.J. Everett and J.M. Gill, Cholesterol, transferrin saturation, and the development of dementia and Alzheimer's disease: Results from an 18-year population-based cohort, Fam Med 37 (2005), 36-42.
57. A. McCaddon, Homocysteine and cognition - a historical perspective, J Alzheimers Dis 9 (2006), 361-380.
58. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price and E.M. Stadlan, Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology 34 (1984), 939-944.
59. H. Misonou, M. Morishima-Kawashima and Y. Ihara, Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells, Biochemistry 39 (2000), 6951-6959.
60. S. Moalem, M.E. Percy, D.F. Andrews, T.P. Kruck, S. Wong, A.J. Dalton, P. Mehta, B. Fedor and A.C. Warren, Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am J Med Genet 93 (2000), 58-66.
61. S. Moalem, E.D. Weinberg and M.E. Percy, Hemochromatosis and the enigma of misplaced iron: Implications for infectious disease and survival, Biometals 17 (2004), 135-139.
62. M.C. Morris, D.A. Evans, J.A. Schneider, C.C. Tangney, J.L. Bienias and N.T. Aggarwal, Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease, J Alzheimers Dis 9 (2006), 435-443.
63. S. Mueller, Iron regulatory protein 1 as a sensor of reactive oxygen species, Biofactors 24 (2005), 171-181.
64. J. Mutter, J. Naumann, C. Sadaghiani, R. Schneider and H. Walach, Alzheimer disease: Mercury as a pathogenetic factor and apolipoprotein E as a moderator, Neuro Endocrinol Lett 25 (2004), 331-339.
65. T. Offer, B.N. Ames, S.W. Bailey, E.A. Sabens, M. Nozawa and J.E. Ayling, 5 Methyltetrahydrofolate inhibits photosensitization reactions and strand breaks in DNA, FASEB J 21 (2007), 2101-2107.
66. Online Mendelian Inheritance in Man. Hemochromatosis, hereditary, Retrieved September 11, 2007, from http://www.ncbi.nlm.nih.gov/entrez/dispomim. cgi?id=235200.
67. Oregon Status University Website: Linus Pauling Institute Micronutrient Institute for Optimum Health - Folic Acid, Retrieved September 25, 2007, from http://lpi.oregonstate.edu/infocenter/vitamins/fa/fig02-2.jpg.
68. R.B. Oria, P.D. Patrick, J.A. Blackman, A.A. Lima and R.L. Guerrant, Role of apolipoprotein E4 in protecting children against early childhood diarrhea outcomes and implications for later development, Med Hypotheses 68 (2007), 1099-1107.
69. K. Pantopoulos, Iron metabolism and the IRE/IRP regulatory system: An update, Ann N Y Acad Sci 1012 (2004), 1-10.
70. R.S. Pappas, G.M. Polzin, C.H. Watson and D.L. Ashley, Cadmium, lead, and thallium in smoke particulate from counterfeit cigarettes compared to authentic US brands, Food Chem Toxicol 45 (2007), 202-209.
71. B.S. Patro, S. Adhikari, T. Mukherjee and S. Chattopadhyay, Possible role of hydroxyl radicals in the oxidative degradation of folic acid, Bioorg Med Chem Lett 15 (2005), 67-71.
72. B.S. Patro, S. Adhikari, T. Mukherjee and S. Chattopadhyay, Folic acid as a Fenton-modulator: Possible physiological implication, Med Chem 2 (2006), 407-413.
73. H. Payami, M. Zhu, J. Montimurro, R. Keefe, C.C. McCulloch and L. Moses, One step closer to fixing association studies: Evidence for age- and gender-specific allele frequency variations and deviations from Hardy-Weinberg expectations in controls, Hum Genet 118 (2005), 322-330.
74. M.E. Percy and D.F. Andrews, Risk estimation in X-linked recessive genetic diseases: Theory and practice, Can J Public Health 77(Suppl 1) (1986), 174-183.
75. J. Poirier, J. Davignon, D. Bouthillier, S. Kogan, P. Bertrand and S. Gauthier, Apolipoprotein E polymorphism and Alzheimer's disease, Lancet 342 (1993), 697-679.
76. J.F. Pulliam, C.D. Jennings, R.J. Kryscio, D.G. Davis, D. Wilson, T.J. Montine, F.A. Schmitt and W.R. Markesbery, Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE, Am J Med Genet B Neuropsychiatr Genet 119 (2003), 48-53.
77. G. Ravaglia, P. Forti, F. Maioli, M. Martelli, L. Servadei, N. Brunetti, E. Porcellini and F. Licastro, Homocysteine and folate as risk factors for dementia and Alzheimer disease, Am J Clin Nutr 82 (2005), 636-643.
78. J.G. Ray, Folic acid food fortification in Canada, Nutr Rev 62(6 Pt 2) (2004), S35-S39.
79. K.J. Robson, D.J. Lehmann, V.L. Wimhurst, K.J. Livesey, M. Combrinck, A.T. Merryweather-Clarke, D.R. Warden and A.D. Smith, Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease, J Med Genet 41 (2004), 261-265.
80. E.J. Rogers, S. Chen and A. Chan, Folate deficiency and plasma homocysteine during increased oxidative stress, N Engl J Med 357 (2007), 421-422.
81. P.S. Rohrlich, N. Fazilleau, F. Ginhoux, H. Firat, F. Michel, M. Cochet, N. Laham, M.P. Roth, S. Pascolo, F. Nato, H. Coppin, P. Charneau, O. Danos, O. Acuto, R. Ehrlich, J. Kanellopoulos and F.A. Lemonnier, Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function, Proc Natl Acad Sci USA 102 (2005), 12855-12860.
82. C.N. Roy, A.O. Custodio, J. de Graaf, S. Schneider, I. Akpan, L.K. Montross, M. Sanchez, A. Gaudino, M.W. Hentze, N.C. Andrews and M.U. Muckenthaler, An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice, Nat Genet 36 (2004), 573-580.
83. L. Salter-Cid, A. Brunmark, Y. Li, D. Leturcq, P.A. Peterson, M.R. Jackson and Y. Yang, Transferrin receptor is negatively modulated by the hemochromatosis protein HFE: Implications for cellular iron homeostasis, Proc Natl Acad Sci USA 96 (1999), 5434-5439.
84. L. Salter-Cid, A. Brunmark, P.A. Peterson and Y. Yang, The major histocompatibility complex-encoded class I-like HFE abrogates endocytosis of transferrin receptor by inducing receptor phosphorylation, Genes Immun 1 (2000), 409-417.
85. L. Salter-Cid, P.A. Peterson and Y. Yang, The major histocompatibility complex-encoded HFE in iron homeostasis and immune function, Immunol Res 22 (2000), 43-59.
86. M. Sampietro, L. Caputo, A. Casatta, M. Meregalli, A. Pellagatti, J. Tagliabue, G. Annoni and C. Vergani, The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease, Neurobiol Aging 22 (2001), 563-568.
87. D.E. Schmechel, J. Browndyke and A. Ghio, Strategies for dissecting genetic-environmental interactions in neurodegenerative disorders, Neurotoxicology 27 (2006), 637-657.
88. S. Sheshadri, Elevated plasma homocysteine levels: Risk factor or risk marker for the development of dementia and Alzheimer's disease? J Alzheimers Dis 9 (2006), 393-398.
89. Q. Shi and G.E. Gibson, Oxidative stress and transcriptional regulation in Alzheimer disease, Alzheimer Dis Assoc Disord 21 (2007), 276-291.
90. W.G. Siems, O. Sommerburg and T. Grune, Erythrocyte free radical and energy metabolism, Clin Nephrol 53(1 Suppl) (2000), S9-S17.
91. K. Simonsen, J. Dissing, L. Rudbeck and M. Schwartz, Rapid and simple determination of hereditary haemochromatosis mutations by multiplex PCR-SSCP: Detection of a new polymorphic mutation, Ann Hum Genet 63(Pt 3) (1999), 193-197.
92. M.K. Stott, A.P. Fellowes, J.D. Upton, M.J. Burt and P.M. George, Simple multiplex PCR for the simultaneous detection of the C282Y and H63D hemochromatosis (HFE) gene mutations, Clin Chem 45(3) (1999), 426-428.
93. F. Tamaoka, S. Miyatake, K. Matsuno, S. Ishii, N. Nagase, S. Sahara, H. Ono, K. Mori, S. Wakabayashi, H. Tsuji, H. Takahashi and S. Shoji, Apolipoprotein E allele-dependent antioxidant activity in brains with Alzheimer's disease, Neurology 54 (2000), 2319-2321.
94. Z.S. Tan, A.S. Beiser, R.S. Vasan, R. Roubenoff, C.A. Dinarello, T.B. Harris, E.J. Benjamin, R. Au, D.P. Kiel, P.A. Wolf and S. Seshadri, Inflammatory markers and the risk of Alzheimer disease: The Framingham Study, Neurology 68 (2007), 1902-1908.
95. J.L. Third, M.D. Ryan, R.B. Sothern, S. Dawson, J.B. McCormick, H.S. Hoffman, A. Gathing, R.A. Jankowski, K.S. Kania and E.L. Kanabrocki, Circadian distribution of iron and ferritin in serum of healthy and type 2 diabetic males, Clin Ter 157 (2006), 35-40.
96. B.M. Todorich and J.R. Connor, Redox metals in Alzheimer's disease, Ann N Y Acad Sci 1012 (2004), 171-178.
97. D. Tomatsu, K.O. Orii, R.E. Fleming, C.C. Holden, A. Waheed, R.S. Britton, M.A. Gutierrez, S. Velez-Castrillon, B.R. Bacon and W.E. Sly, Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis, Proc Natl Acad Sci USA 199 (2003), 15788-15793.
98. Veal E.A., A.M. Day and B.A. Morgan, Hydrogen peroxide sensing and signaling, Mol Cell 26 (2007), 1-14.
99. F.T. Wang, H. Hu, J. Schwartz, J. Weuve, A.S. Spiro, D. Sparrow, H. Nie, E.K. Silverman, S.T. Weiss and R.O. Wright, Modifying effects of the HFE polymorphisms on the association between lead burden and cognitive decline, Environ Health Perspect 115 (2007), 1210-1215.
100. P.R. Wenham, W.H. Price and G. Blandell, Apolipoprotein E genotyping by one-stage PCR, Lancet 337 (1991), 1158-1159.